Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

What are the long-term symptoms of SARS-CoV-2 infection?

Researchers determines whether some symptoms of long-COVID are more specifically associated with SARS-CoV-2 infection than other conditions.

4 Apr 2022

How sleep and mental health were affected in Sweden during the COVID-19 pandemic

Researchers uncovered the relationship between mental health and sleep in Sweden during the SARS-CoV-2 pandemic.

4 Apr 2022

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Researchers analyzed sera samples of 400 participants of the PARIS study to evaluate the risk of SARS-CoV-2 infection and seroreversion for an average of 84 days.

4 Apr 2022

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

Researchers conducted selective phenotyping of coronavirus disease 2019 -relevant host proteins to facilitate target identification for drug repurposing.

4 Apr 2022

The emergence and limited spread of the Mu SARS-CoV-2 variant

A recent report provides insights into the restricted worldwide spread of the SARS-CoV-2 Mu (B.1.621) variant.

4 Apr 2022

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

A recent study presented the rapid spike in COVID-19 seroprevalence during the emergence of the Omicron variant in Finland.

4 Apr 2022

Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

Researchers investigated the effect of repeated alcohol exposure and withdrawal on angiotensin-converting enzyme 2 and transmembrane serine protease 2 expression, putative regulators of SARS-CoV-2 entry, in discrete brain regions.

4 Apr 2022

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

A new study estimated the risk and prevalence of acute respiratory distress syndrome in hospitalized young adults with SARS-CoV-2 infection.

4 Apr 2022

The effects of SARS-CoV-2 infection in different ancestry origins from the same region

Researchers examined whether varied allelic frequencies of the HLA gene in people of different ancestral origins were associated with increased susceptibility to SARS-CoV-2 infection and disease severity.

4 Apr 2022

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

A new preprint describes the importance of recognizing this complication, reporting a case of MIS-C without a prior history of this infection.

4 Apr 2022

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Researchers discussed the stability of spike antibody titers mounted against SARS-CoV-2 infection, and their ability to protect from infection with antigenically similar variants.

4 Apr 2022

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

A new Swedish study examines the protective effect of immunity engendered by natural infection in contrast to hybrid immunity.

4 Apr 2022

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

In a recent study published in the journal PLOS Genetics, researchers explored severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) ribonucleic acid (RNA) editing in host cells.

4 Apr 2022

COVID-19 study proves ivermectin ineffective

A recent study published in the New England Journal of Medicine investigated the impact of ivermectin, an antiparasitic drug, as an early treatment option among coronavirus disease 2019 (COVID-19) patients.

4 Apr 2022

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

In a recent study published in the journal Science, researchers observed differential effector functions of antibodies elicited by Pfizer’s BNT162b2 and Moderna’s messenger ribonucleic acid (mRNA)-1273 coronavirus disease 2019 (COVID-19) vaccines.

4 Apr 2022

How well does the BNT162b2 vaccine protect children and teens against Omicron?

A study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2) vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in children and adolescents.

4 Apr 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

What are the long-term symptoms of SARS-CoV-2 infection?

How sleep and mental health were affected in Sweden during the COVID-19 pandemic

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

The emergence and limited spread of the Mu SARS-CoV-2 variant

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

The effects of SARS-CoV-2 infection in different ancestry origins from the same region

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

COVID-19 study proves ivermectin ineffective

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

How well does the BNT162b2 vaccine protect children and teens against Omicron?

Smart toilets for passive surveillance of SARS-CoV-2

The effect of COVID-19 on the lung function of young adults

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

TLR7 and MARK1 genomic variants impact COVID-19 prognosis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in